Microglia/Macrophages and Neuroprotection in Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2005 - March 31, 2007
Grant ID
G2005001
Summary
Glaucoma is a chronic disease in which the neurons, called retinal ganglion cells, undergo degeneration. Another trait of developing glaucoma is an increase of pressure within the eyes. Recently, a novel approach was proposed to utilize our body immunity to protect neurons in the eyes. Dr. Chang’s study aims to define which factors or what conditions for the activation of innate immune cells can lead these cells to elicit protective effects. He will also study how a Chinese medicine, Chinese Wolfberry, exhibits protective effects to neurons in the eyes via mild activation of innate immune cells. Knowledge of how body immunity exerts protective effects to neurons in the eyes will hopefully pave a new road for therapeutic intervention against loss of vision in glaucoma.
Related Grants
National Glaucoma Research
Understanding How Variants in LOXL1 Affect Pseudoexfoliation Glaucoma Risk
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Hannah Youngblood, PhD
Current Organization
Georgia Institute of Technology
National Glaucoma Research
Retinal Ganglion Cell Axon Degeneration in a 3D Microfluidic Hydrogel Model
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Shruti Patil, PhD
Current Organization
Indiana University School of Medicine
National Glaucoma Research
The Role of Microtubules in Glaucomatous Schlemm’s Canal Mechanobiology
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Haiyan Li, PhD
Current Organization
Georgia Institute of Technology